Skip to main content

Advertisement

Open Peer Review Reports for: Cryptotanshinone activates AMPK-TSC2 axis leading to inhibition of mTORC1 signaling in cancer cells

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
14 Jun 2016 Submitted Original manuscript
5 Jul 2016 Reviewed Reviewer Report - Wei Zhou
19 Jul 2016 Reviewed Reviewer Report - Xuerong Wang
6 Aug 2016 Author responded Author comments - Wenxing Chen
Resubmission - Version 2
6 Aug 2016 Submitted Manuscript version 2
12 Aug 2016 Reviewed Reviewer Report - Xuerong Wang
18 Aug 2016 Reviewed Reviewer Report - Wei Zhou
7 Sep 2016 Author responded Author comments - Wenxing Chen
Resubmission - Version 3
7 Sep 2016 Submitted Manuscript version 3
11 Oct 2016 Author responded Author comments - Wenxing Chen
Resubmission - Version 4
11 Oct 2016 Submitted Manuscript version 4
Publishing
22 Dec 2016 Editorially accepted
7 Jan 2017 Article published 10.1186/s12885-016-3038-y

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement